The physician does not necessarily have to have direct face-to-face contact with the patient for these fees to be paid.
00039 is the only fee payable for any visit or medically necessary service associated with methadone maintenance therapy. This includes but is not limited to the following:
a) At least one visit per week with the patient during the induction of methadone or buprenorphine/naloxone/methadone or buprenorphine/naloxene stabilization.
b) At least two visits per month with the patient after induction/ stabilization on methadone or buprenorphine/naloxone is complete. Exceptions to this criterion are where the patient resides/works in an isolated locale which is a significant distance from the prescribing physician.
c) Case management/treatment planning with care team.
d) Supervised urine drug screening and interpretation of results.
e) Counselling by a physician.
f) Communication with non-physician counsellor.
g) Communication with dispensing/supervising pharmacist.
h) Communication with primary care physician.
i) Communication with hospital-based physician when patient admitted to hospital.
j) Completion and submission of documentation relating to registration, termination or transfer.
Claims for visit fees are not payable in addition.
iv) This fee is payable once per week per patient regardless of the number of visits per week.
v) This fee is not payable with out of office hours premiums.
vi) Eligibility to submit claims for this fee item is limited to physicians who:
a) have a current valid license to prescribe methadone or buprenorphine/naloxone for addiction.
b) are actively supervising the patient’s continuing use of methadone or buprenorphine/naloxone within the provincial methadone program.
vii) This payment stops when the patient stops taking methadone or buprenorphine/naloxone.